BAY-858101

N/A

Report date: 2025/11/24 17:58:24

NME

Base Information

Drug NameBAY-858101

Drug Alias Name[18F]-FEDAA-1106BAY-85-8101ZK-6032924

ClassificationSmall molecules > Heterocyclic drugsRadiation-emitting products > Radioactive diagnostic agentRadiation-emitting products > Nuclides > Fluorine > 18F +[5]

Mechanisms of ActionTranslocator protein ligands

TargetsTranslocator protein

Therapy Area/IndicationsAlzheimer DiseaseMultiple Sclerosis

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritorySwedenNetherlandsAustralia

CombinationsNo

Global Highest StatusPending (Phase 1 Clinical)

Highest Status in ChinaN/A

Originator CompaniesBayer AG

China Registration ClassN/A

Develop Information

Active CompaniesN/A

Inactive CompaniesBayer AG

Active IndicationsN/A

Inactive IndicationsAlzheimer DiseaseMultiple Sclerosis

Other Information

ATC CodeN/A